Indications of underdiagnosis of atypical haemolytic uraemic syndrome in a cohort referred to the Coagulation Unit in Malmo, Sweden, for analysis of ADAMTS13 2007–2012 - Åkesson, Alexander; Blom, Anna M; Klintman, Jenny; Zetterberg, Eva (Nephrology (Carlton, Vic.), 2017)
Keywords: acute kidney injury; ADAM protein; ADAMTS13 Protein - blood; Adolescent; Adult; Aged; Aged, 80 and over; Alternative pathway; anaemia, haemolytic; Anemia; Antibodies; Atypical Hemolytic Uremic Syndrome - blood; Atypical Hemolytic Uremic Syndrome - diagnosis; Atypical Hemolytic Uremic Syndrome - epidemiology; Atypical Hemolytic Uremic Syndrome - immunology; Autoantibodies - blood; Biomarkers - blood; Child; Child, Preschool; Clinical Medicine; Coagulation; Complement Activation; Complement component C3; Complement component C4; Complement factor H; complement pathway, alternative; Complement system; Complement System Proteins - analysis; Female; Hemolytic anemia; Humans; Immunoglobulins; Infant; Infant, Newborn; Kidneys; Klinisk medicin; Male; Medical and Health Sciences; Medicin och hälsovetenskap; microcirculation; Middle Aged; Morbidity; Predictive Value of Tests; Prevalence; Purpura; Rare diseases; Referral and Consultation; Renal failure; Reproducibility of Results; Retrospective Studies; Reviews; Risk Factors; Sweden - epidemiology; thrombocytopaenia; Thrombocytopenia; Thrombocytopenic purpura; Thrombospondin; Thrombotic thrombocytopenic purpura; Young Adult; Sweden; acute kidney injury; thrombocytopaenia; anaemia, haemolytic; microcirculation; complement pathway, alternative